ADFD

Hier entsteht eine Liste von Publikationen, die zum Thema Psychopharmaka, Einnahme, Nebenwirkungen, Entzug relevant sind.

Die Liste ist nach Jahreszahlen geordnet, darunter alphabetisch nach den Erstautoren.

2016

Akoudad,S., Aarts, N., Noordam, R., Ikram, M. A., Tiemeier, H., Hofman, A., Stricker, B. H., Vernooij, M. W., Visser, L. E.
(2016): Antidepressant Use Is Associated With an Increased Risk of Developing Microbleeds. Stroke 47: 251-254
doi: 10.1161/STROKEAHA.115.011574 http://stroke.ahajournals.org/content/4 ... fc612c61ac

Breggin, PR. (2016): Rational Principles of Psychopharmacology for Therapists, Healthcare Providers and Clients. J Contemp Psychother 46:1–13. http://breggin.com/index.php?option=com ... &Itemid=37

Lucire, Y. (2016): Pharmacological Iatrogenesis: Substance/Medication-Induced Disorders That Masquerade as Mental Illness. Epidemiology (sunnyvale) 6:1 http://dx.doi.org/10.4172/2161-1165.1000217

Satoshi Ueda, Takeshi Sakayori, Ataru Omori, Hajime Fukuta, Takashi Kobayashi, Kousuke Ishizaka, Tomoyuki Saijo, Yoshiro Okubo (2016): Neuroleptic-induced deficit syndrome in bipolar disorder with psychosis Neuropsychiatr Dis Treat. 2016; 12: 265–268. doi: 10.2147/NDT.S99577
PMCID: PMC4745952 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745952/

Sharma, T., Schow Guski, L., Freund, N., Gøtzsche, P. C. (2016): Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports British Medical Journal 352:i65 doi: http://dx.doi.org/10.1136/bmj.i65 http://www.bmj.com/content/352/bmj.i65.full.pdf+html

Uher, R., Pavlova, B. (2016): Long-term effects of depression treatment. The Lancet Psychiatry 3 (2): 95 - 96 http://dx.doi.org/10.1016/S2215-0366(15)00578-7 http://www.thelancet.com/pdfs/journals/ ... 0578-7.pdf

2015

Amerio, A., Gálvez, J. F. Odone, A., Dalley, S. A., Ghaemi, S. N. (2015): Carcinogenicity of psychotropic drugs: A systematic review of US Food and Drug Administration–required preclinical in vivo studies. Australian & New Zealand Journal of Psychiatry 49(8): 686–696 DOI: 10.1177/0004867415582231 http://anp.sagepub.com/content/49/8/686.full.pdf+html

Andrews, P. W., Bharwania, A., Leea, K. R., Fox, M., Anderson Thomson, J., Jr. (2015): Is serotonin an upper or a downer? The evolution of the serotonergic system and its role in depression and the antidepressant response. Neuroscience & Biobehavioral Reviews 51: 164–188
doi:10.1016/j.neubiorev.2015.01.018 http://www.sciencedirect.com/science/ar ... 3415000287

Chouinard, G., Chouinard, V. (2015): New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal. Psychother Psychosom 84:63-71. DOI:10.1159/000371865 http://www.karger.com/Article/Pdf/371865

Cressman, A. M., Macdonald, E. M., Huang, A., Gomes, T., Paterson, M., Kurdyak, P. A., Mamdani, M. M., Juurlink, D. N.
(2015): Prescription Stimulant Use and Hospitalization for Psychosis or Mania: A Population-Based Study. Journal of Clinical Psychopharmacology 35(6): 667–671 doi: 10.1097/JCP.0000000000000406 http://journals.lww.com/psychopharmacol ... for.8.aspx

Fava, G.A., Guidi, J., Rafanelli, C., Sonino, N. (2015): The Clinical Inadequacy of Evidence-Based Medicine and the Need for a Conceptual Framework Based on Clinical Judgment. Psychother Psychosom 84:1-3 DOI:10.1159/000366041 http://www.karger.com/Article/Pdf/366041

Lacasse, J. R., Leo, J. (2015): Antidepressants and the Chemical Imbalance Theory of Depression: A Reflection and Update on the Discourse. The Behavior Therapist 38(7): 206-213. https://www.researchgate.net/publicatio ... _Discourse

Le Noury, J., Nardo, J. M., Healy, D., Jureidini, J., Raven, M., Tufanaru, C., Abi-Jaoude, E. (2015): Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence BMJ 2015;351:h4320 doi:10.1136/bmj.h4320 http://study329.org/wp-content/uploads/ ... -Final.pdf

Moncrieff, J. (2015): Antidepressants: misnamed and misrepresented. World Psychiatry 14(3): 302–303 DOI: 10.1002/wps.20243 http://onlinelibrary.wiley.com/doi/10.1 ... 20243/epdf

Takayanagi, Y., Spira, A.P., Bienvenu, O.J., Hock, R.S., Carras, M.C., Eaton, W.W., Mojtabai, R. (2015): Antidepressant use and lifetime history of mental disorders in a community sample: results from the Baltimore Epidemiologic Catchment Area Study. J Clin Psychiatry 76(1):40-4
doi: 10.4088/JCP.13m08824 http://www.ncbi.nlm.nih.gov/pmc/article ... 695626.pdf

2014

Breggin, P. R. (2014): The Rights of Children and Parents In Regard to Children Receiving Psychiatric Diagnoses and Drugs. Children & Society, 28, (2014) pp. 231-241 http://breggin.com/index.php?option=com ... &Itemid=37

Maund, E., Tendal, B.,Hróbjartsson, A.,Jørgensen, K. J., Lundh, A., Schroll, J., Gøtzsche, P. C. (2014): Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications BMJ 2014; 348 doi: http://dx.doi.org/10.1136/bmj.g3510 http://www.bmj.com/content/bmj/348/bmj.g3510.full.pdf

Moncrieff, J. (2014): The Nature of Mental Disorder: Disease, Distress, or Personal Tendency? Philosophy, Psychiatry, & Psychology 21;3: 257-260 http://muse.jhu.edu/journals/philosophy ... rieff.html

Read, J., Cartwright, C., Gibson, K. (2014): Adverse emotional and interpersonal effects reported by 1829 New Zealanders while taking antidepressants. Psychiatry Res. 30;216(1):67-73 doi: 10.1016/j.psychres.2014.01.042 http://www.ncbi.nlm.nih.gov/pubmed/24534123

Thomas, . H., Martin, R. M., Potokar, J., Pirmohamed, M., Gunnell, D. (2014): Reporting of drug induced depression and fatal and non-fatal suicidal behaviour in the UK from 1998 to 2011. BMC Pharmacol Toxicol.15: 54. doi: 10.1186/2050-6511-15-54 PMCID: PMC4184159 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184159/

2013

Nielsen, M., Hansen, E.H., Gøtzsche P.C.(2013): Dependence and withdrawal reactions to benzodiazepines and selective serotonin reuptake inhibitors. How did the health authorities react? GInt J Risk Saf Med 25(3):155-68. doi: 10.3233/JRS-130594. http://www.ncbi.nlm.nih.gov/pubmed/24047687

Prousky, J. E. (2013): Tapering Off Psychotropic Drugs: Using Patient Cases to Understand Reasons for Success and Failure. Journal of Orthomolecular Medicine 28:4 159-174 http://www.jonathanprouskynd.com/upload ... ailure.pdf

Renoir, T. (2013): Selective Serotonin Reuptake Inhibitor Antidepressant Treatment Discontinuation Syndrome: A Review of the Clinical Evidence and the Possible Mechanisms Involved. Front Pharmacol 4: 45 doi: 10.3389/fphar.2013.00045 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627130/

2012

Antonuccio,D., Healy, D, (2012): Relabeling the Medications We Call Antidepressants. Scientifica, vol. 2012, Article ID 965908, 6 pages. doi:10.6064/2012/965908 http://www.hindawi.com/journals/scienti ... 65908/cta/

Breggin, P. R. (2012): Psychiatric drug-induced Chronic Brain Impairment (CBI): Implications for longterm treatment with psychiatric medication International Journal of Risk & Safety in Medicine 23: 193-200. http://breggin.com/index.php%3Foption%3 ... temid%3D37

Nielsen, M., Hansen, E.H., Gøtzsche, P.C. (2012): What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re-uptake inhibitors. Addiction 107(5):900-8. doi: 10.1111/j.1360-0443.2011.03686.x. http://www.ncbi.nlm.nih.gov/pubmed/21992148

2011

Andrews, P. W., Kornstein, S., G., Halberstadt, L. J., Gardner, C. O., Neale, M. C.(2011): Blue again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression Front Psychol 2: 159. doi: 10.3389/fpsyg.2011.00159 http://www.ncbi.nlm.nih.gov/pmc/article ... -00159.pdf

Andrews, P.W., Thomson, J.A., Amstadter, A., Neale, M.C. (2011): Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good Front Psychol. 24;3:117. doi: 10.3389/fpsyg.2012.00117 http://www.ncbi.nlm.nih.gov/pmc/article ... -00117.pdf

El-Mallakh, R. S., Gao, Y., Jeannie Roberts, R. (2011): Tardive dysphoria: the role of long term antidepressant use in-inducing chronic depression Med Hypotheses 76(6):769-73 doi: 10.1016/j.mehy.2011.01.020 http://www.ncbi.nlm.nih.gov/pubmed/21459521

Fava, G.A., Offidani E. (2011): The mechanisms of tolerance in antidepressant action. Prog Neuropsychopharmacol Biol Psychiatry. 5;35(7):1593-602. doi: 10.1016/j.pnpbp.2010.07.026 http://www.ncbi.nlm.nih.gov/pubmed/20728491

Furukawa, T.A. (2011): Rapid discontinuation of antidepressants reduces time to recurrence of depression and panic
Evid Based Mental Health 14:13 doi:10.1136/ebmh1131 http://ebmh.bmj.com/content/14/1/13.extract

Goldsmith, L., Moncrieff, J. (2011): The Psychoactive Effects of Antidepressants and their Association with Suicidality. Current Drug Safety Vol 6(2): 115-121(7) https://joannamoncrieff.files.wordpress ... ds0311.pdf

Middleton, H., Moncrief, J. (2011): 'They won't do any harm and might do some good': Time to think again on the use of antidepressants? British Journal of General Practice 61:47–49 DOI:10.3399/bjgp11X548983 http://www.ncbi.nlm.nih.gov/pmc/article ... 61-047.pdf

Nielsen M., Gøtzsche P. (2011): An analysis of psychotropic drug sales. Increasing sales of selective serotonin reuptake inhibitors are closely related to number of products Int J Risk Saf Med. 23(2):125-32. doi: 10.3233/JRS-2011-0526 http://www.ncbi.nlm.nih.gov/pubmed/21673422

Narayan, V., Haddad, P.M. (2011): Antidepressant discontinuation manic states: a critical review of the literature and suggested diagnostic criteria.
J Psychopharmacol. 25(3):306-13. http://www.ncbi.nlm.nih.gov/pubmed/20156925


van Donkelaar, E. L., Blokland, A., Ferrington, L., Kelly, P.A.T., Steinbusch, H.W.M., Prickaerts, J. (2011): Mechanism of acute tryptophan depletion: is it only serotonin? Molecular Psychiatry 16, 695–713 http://www.nature.com/mp/journal/v16/n7 ... 20119a.pdf

2010

Baldessarini, R.J., Tondo, L., Ghiani, C., Lepri, B. (2010): Illness risk following rapid versus gradual discontinuation of antidepressants. Am J Psychiatry 167(8):934-41. doi: 10.1176/appi.ajp.2010.09060880 http://ajp.psychiatryonline.org/doi/abs ... b%3Dpubmed

Howland, R.H. (2010): Potential adverse effects of discontinuing psychotropic drugs. Part 1: Adrenergic, cholinergic, and histamine drugs.J Psychosoc Nurs Ment Health Serv. 2010 Jun;48(6):11-4. http://www.mediafire.com/download/uuwnd ... nergic.pdf

Howland, R.H. (2010): Potential adverse effects of discontinuing psychotropic drugs. Part 2: antidepressant drugs. J Psychosoc Nurs Ment Health Serv. 2010 Jul;48(7):9-12. doi: 10.3928/02793695-20100527-98. http://www.mediafire.com/download/0572r ... ssants.pdf

Howland, R.H. (2010): Potential adverse effects of discontinuing psychotropic drugs. Part 3: Antipsychotic, dopaminergic, and mood-stabilizing drugs. J Psychosoc Nurs Ment Health Serv. 2010 Aug;48(8):11-4. http://www.mediafire.com/download/xsv6w ... chotic.pdf

Howland, R.H. (2010): Potential adverse effects of discontinuing psychotropic drugs. Part 4: Part 4: Benzodiazepine, Glutamate, Opioid, and Stimulant Drugs. J Psychosoc Nurs Ment Health Serv. 2010 Sep;48(9):11-4. doi: 10.3928/02793695-20100730-04. Epub 2010 Aug 23. http://www.mediafire.com/download/1akzt ... benzos.pdf

Sansone, R.A., Sansone, L.A., (2010): SSRI-Induced Indifference. Psychiatry (Edgemont) 7(10):14–18 http://www.ncbi.nlm.nih.gov/pmc/article ... _10_14.pdf

2006

Moncrieff, J.(2006): Why is it so difficult to stop psychiatric drug treatment? It may be nothing to do with the original problem. Medical Hypotheses 67, 517-523 http://psychrights.org/Articles/Moncrie ... rugred.pdf

Moncrieff, J., Cohen, D. (2006): Do Antidepressants Cure or Create Abnormal Brain States? PLoS Med 3(7): e240 DOI: 10.1371/journal.pmed.0030240 http://www.plosmedicine.org/article/fet ... tation=PDF

Shelton, R.C. (2006): The nature of the discontinuation syndrome associated with antidepressant drugs. J Clin Psychiatry. 2006;67 Suppl 4:3-7. http://www.mediafire.com/download/1ax1a ... helton.pdf

2004

Breggin, P. R. (2004): Suicidality, violence and mania caused by selective serotonin reuptake inhibitor (SSRIs): A review and analysis. International Journal of Risk & Safety in Medicine 16:31–49 http://www.breggin.com/31-49.pdf

Meyer, J. H., Wilson, A. A., Sagrati, S., Hussey, D., Carella, A.,Potter, W. Z., Ginovart, N., Spencer, E. P., Cheok, A., Houle, S. (2004): Serotonin Transporter Occupancy of Five Selective Serotonin Reuptake Inhibitors at Different Doses: An [11C]DASB Positron Emission Tomography Study Am J Psychiatry 161:826–835 http://ils.unc.edu/bmh/neoref/nrschizop ... mp/352.pdf

2003

Fava, G. A. (2003): Can Long-Term Treatment With Antidepressant Drugs Worsen the Course of Depression? J Clin Psychiatry 64:123–133 http://www.madinamerica.com/wp-content/ ... ession.pdf

2002

Shipko, S. (2002): Serotonin Reuptake Inhibitor Withdrawal: Out of the Frying Pan and Into the Fire. Ethical Human Sciences and Services 4(2):83 - 91 https://www.researchgate.net/publicatio ... o_the_Fire

2001

Schweitzer, I., Maguire,K. (2001): Stopping antidepressants. Aust Prescr 2001;24:13-5 http://dx.doi.org/10.18773/austprescr.2001.008

2000

van Weel-Baumgarten, E.M., van den Bosch, W.J., Hekster, Y.A., van den Hoogen, H.J., Zitman, F.G. (2000): Treatment of depression related to recurrence: 10-year follow-up in general practice J Clin Pharm Ther 25(1):61-6 http://www.ncbi.nlm.nih.gov/pubmed/10771465

1998

Goldberg, D., Privett, M., Ustun, B., Simon, G., Linden, M. (1998): The effects of detection and treatment on the outcome of major depression in primary care: a naturalistic study in 15 cities.Br J Gen Pract. 48(437): 1840–1844 http://www.ncbi.nlm.nih.gov/pmc/article ... 198504.pdf

Tranter, R.; Healy, D. (1998): “Neuroleptic Discontinuation Syndromes.” Journal of Psychopharmacology 12 (4): 401-06. DOI: 10.1177/026988119801200412 https://www.google.de/url?sa=t&rct=j&q= ... 6328,d.ZGg

1994

Lewander T. (1994): Neuroleptics and the neuroleptic-induced deficit syndrome. Acta Psychiatr Scand Suppl. 380:8-13. http://www.ncbi.nlm.nih.gov/pubmed/7914056

1991

Hoehn-Saric, R; Harris, GJ; Pearlson, GD; Cox, CS; Machlin, SR; Camargo, EE. (1991): A Fluoxetin-Induced Frontal Lobe Syndrome in an Obsessive Compulsive Patient. Journal of Clinical Psychiatry 52 (3): 131-3 http://www.ncbi.nlm.nih.gov/pubmed/2005077

1989

Baker, G.B.; Greenshaw, A.J. (1989): Effects of Long-Term Administration of Antidepressants and Neuroleptics on Receptors in
the Central Nervous System. Cellular and Molecular Neurobiology. 1989 (vol 9, no1): 1-44. http://www.ncbi.nlm.nih.gov/pubmed/2565769

1980

Hodding, G. C., Jann, M., and Ackerman, I. P. (1980): Drug Withdrawal Syndromes A Literature Review. West J Med. 1980 Nov; 133(5): 383–391.
PMCID: PMC1272349 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1272349/